Newsweek International  |  24 February 2017
THE WAR ON ALZHEIMER'S
This aggressive attempt to prevent Alzheimer’s rather than treating it is the most exciting new development in decades, as well as a radical departure for researchers and the pharmaceutical industry. Traditionally, drug companies have tested their therapies on patients who already have memory loss, trouble thinking and other signs of dementia. It’s been a losing tactic: More than ninety nine percent of all Alzheimer’s drugs have failed tests in the clinic, and the few that have made it to the market only ameliorate some symptoms. No single medicine has been shown to slow the relentless progression of the disease. However this new approach, even partial success an appreciable slowing of brain degeneration could have a big impact, says Dr. Reisa Sperling, a neurologist who directs the Center for Alzheimer’s Researc.
ler mais
ler menos
Como subscritor, receberá as seguintes vantagens
• Um desconto no PVP da sua revista
• A sua revista entregue no seu dispositivo todos os meses
• Nunca perderá uma edição
• Está protegido contra aumentos de preços que possam ocorrer no final do ano
Receberá 51 edições durante um ano Newsweek International assinatura da revista.
Nota: As edições digitais não incluem os artigos de capa ou os suplementos que se encontram nos exemplares impressos.
Artigos desta edição
Segue-se uma seleção de artigos em Newsweek International 24 February 2017.